ProfileGDS4718 / 239269_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 62% 59% 51% 57% 53% 55% 56% 56% 53% 54% 52% 57% 49% 54% 56% 58% 52% 52% 54% 37% 56% 55% 52% 58% 58% 51% 57% 55% 61% 54% 53% 50% 63% 62% 58% 49% 54% 57% 54% 53% 52% 65% 53% 49% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.2837662
GSM549102patient 115, normal, homogenized [OPG study]6.052859
GSM549104patient 119, normal, homogenized [OPG study]5.5581851
GSM549108patient 138, normal, homogenized [OPG study]5.9515657
GSM549119patient 077, normal, homogenized [OPG study]5.6941453
GSM549133patient 032, cancer, homogenized [OPG study]5.7670255
GSM549139patient 042, cancer, homogenized [OPG study]5.8643256
GSM549099patient 107, normal, homogenized [OPG study]5.8387556
GSM549109patient 139, normal, homogenized [OPG study]5.6789753
GSM549110patient 046, normal, homogenized [OPG study]5.7492554
GSM549114patient 063, normal, homogenized [OPG study]5.5674952
GSM549122patient 082, normal, homogenized [OPG study]5.9762757
GSM549134patient 033, cancer, homogenized [OPG study]5.4239949
GSM549136patient 036, cancer, homogenized [OPG study]5.7298654
GSM549140patient 044, cancer, homogenized [OPG study]5.8564856
GSM549111patient 047, normal, homogenized [OPG study]6.0083458
GSM549113patient 057, normal, homogenized [OPG study]5.6020652
GSM549132patient 031, cancer, homogenized [OPG study]5.6362352
GSM549137patient 038, cancer, homogenized [OPG study]5.7438554
GSM549142patient 047, cancer, homogenized [OPG study]4.9683537
GSM549100patient 110, normal, homogenized [OPG study]5.8870656
GSM549107patient 135, normal, homogenized [OPG study]5.7579355
GSM549115patient 068, normal, homogenized [OPG study]5.5907352
GSM549116patient 072, normal, homogenized [OPG study]5.9825558
GSM549120patient 078, normal, homogenized [OPG study]6.0176958
GSM549131patient 030, cancer, homogenized [OPG study]5.5027551
GSM549118patient 074, normal, homogenized [OPG study]5.9401457
GSM549129patient 027, cancer, homogenized [OPG study]5.8568155
GSM549123patient 088, normal, homogenized [OPG study]6.1975261
GSM549124patient 006, cancer, homogenized [OPG study]5.7624254
GSM549126patient 015, cancer, homogenized [OPG study]5.6567753
GSM549128patient 025, cancer, homogenized [OPG study]5.4956850
GSM549103patient 117, normal, homogenized [OPG study]6.3001263
GSM549117patient 073, normal, homogenized [OPG study]6.2032962
GSM549138patient 041, cancer, homogenized [OPG study]6.0006258
GSM549141patient 045, cancer, homogenized [OPG study]5.4131749
GSM549130patient 028, cancer, homogenized [OPG study]5.7189454
GSM549101patient 111, normal, homogenized [OPG study]5.9587457
GSM549105patient 128, normal, homogenized [OPG study]5.7789854
GSM549106patient 134, normal, homogenized [OPG study]5.6434653
GSM549112patient 048, normal, homogenized [OPG study]5.6467252
GSM549125patient 011, cancer, homogenized [OPG study]6.4763465
GSM549127patient 024, cancer, homogenized [OPG study]5.6971953
GSM549135patient 035, cancer, homogenized [OPG study]5.4547349